Reply To: Blinatumomab, Dinutuximab, and Other Biotherapy Nurse Staffing Ratios

  • Tristyn Kruger

    Member
    August 31, 2022 at 11:24 am

    I would love to participate!

    Tristyn M. Kruger BSN, RN, CPHON
    Assistant Nurse Manager
    Pediatric Oncology, Hematology, and Bone Marrow Transplant
    Primary Children’s Hospital

    100 North Mario Capecchi Drive | Salt Lake City, UT 84113
    801.662.4571 |Tristyn.Staley@imail.org

    ——————————
    Tristyn Kruger, BSN,RN,CPHON
    West Valley City, UT
    United States
    ——————————
    ——————————————-
    Original Message:
    Sent: 08-30-2022 07:34 AM
    From: Alyssa Henderson
    Subject: Blinatumomab, Dinutuximab, and Other Biotherapy Nurse Staffing Ratios

    Hello everyone!
    I am the assistant nurse manager at Hackensack UMC in Hackensack, NJ and I am looking for documentation to support my inpatient unit’s 1:2 nurse:patient staffing ratio for blinatumomab, dinutuximab, and other biotherapy infusions.  I am in the process of conducting a literature search but not having much luck.  Would you mind sharing your hospital name and pediatric biotherapy infusion staffing ratios (specifically blina & dinutux if possible)?  Also, if anyone has literature to support lower staffing ratios for these infusions I would sincerely appreciate it!  Thank you in advance!!

    ——————————
    Alyssa Henderson, RN, BSN, CPHON
    Inpatient Peds Heme/Onc/BMT Assistant Nurse Manager
    Hackensack, NJ
    ——————————